Jesduvroq

daprodustat

Approval

ApplicationNDA 216951
Approval dateFeb 1, 2023
Approval year2023
SponsorGlaxosmithkline

FDA-approved use

To treat anemia caused by chronic kidney disease for adults on dialysis for at least four months

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Jesduvroq: